INVESTIGADORES
OLIVERI Maria Beatriz
congresos y reuniones científicas
Título:
Effectiveness of a single 100000 IU dose of vitamin D3 in hypovitaminosis D patients
Autor/es:
FERROV; BAGUR A; GONZALEZ D; FERNANDEZ MC; SEIJO M; OLIVERI B; PARISI MS
Lugar:
BsAs
Reunión:
Congreso; XXV Reunion Anual AAOMM; 2008
Institución organizadora:
AAOMM
Resumen:
Effectiveness of a single 100.000IU dose of vitamin D3 in hypovitaminosis
D patients
V. Ferro, A. Bagur, D. Gonz¨¢lez, M.C. Fern¨¢ndez, M. Seijo, B. Oliveri, M.S. Parisi
Secci¨®n Osteopat¨ªas M¨¦dicas, Hospital de Cl¨ªnicas, Universidad de Buenos Aires;
Centro de Osteopat¨ªas M¨¦dicas, Buenos Aires, Argentina
There is no consensus on the adequate dose/scheme to rapidly achieve
desirable 25hydroxivitamin D (25OHD) levels. This study sought to evaluate
the effectiveness of a single 100.000IU dose of vitamin D3 in attaining
desirable 25OHD levels in hypovitaminosis D patients. We analyzed 38
clinical records of women with 25OHD levels <32 ng/ml. Results of serum
calcium, phosphorus, bone alkaline phosphatase, crosslaps and intact
parathormone (iPTH), and urine calcium were analyzed at baseline and at
90 days post-100.000IU/vitD3 administration. Age was 63.3¡À9.6years
(X¡ÀDS). Patients were divided according to baseline 25OHD levels. G1:
<=10 ng/ml (n=2), G2:>10 and<=20 ng/ml (n=19) and G3:>20 and <32 ng/ml
(n=17). iPTH levels were increased in 8 patients. All remaining parameters
were within normal ranges. At day 90, 21 (55%) patients had desirable
25OHD levels (>=32 ng/ml). 25OHD values increased an average 80% in the
whole group, 20.3¡À5.9 vs 33.4¡À8.8 ng/ml (p<0.001), 193% in G1 (9.5¡À0.7 vs
27.5¡À6.4 ng/ml), 111% in G2 (16.5¡À3.1 vs 34.1¡À10.5 ng/ml, p<0.001), and 32%
in G3 (25.7¡À2.5 vs 33.3¡À6.8 ng/ml, p<0.01). Increases correlated inversely
with baseline 25OHD (r:-0.69, p<0.001). 50% of G1, 63% of G2, and 53% of G3
attained 25OHD levels ¡Ý32 ng/ml. High baseline iPTH levels remained
elevated. There were no cases of hypercalcemia/hypercalciuria. 100.000IU of
vit D3 were insufficient to obtain desirable 25OHD (>=32 ng/ml) levels in
almost half the patients, and to normalize iPTH levels. Assessing 25OHD
levels could be useful to determine the need for another dose. A vitD3 dose
above 100.000IU or additional dose, are necessary when desirables levels are
not reached.
doi:10.1016/j.bone.2008.10.012